28 research outputs found

    Um novo método para simular o estado hidrológico do solo em condições naturais

    Get PDF
    Micro, macro and mesofauna in the soil often respond to fluctuating environmental conditions, resulting in changes of abundance and community structure. Effects of changing soil parameters are normally determined with samples taken in the field and brought to the laboratory, i.e. where natural environmental conditions may not apply. We devised a method (STAFD – soil tubes for artificial flood and drought), which simulates the hydrological state of soil in situ using implanted cores. Control tubes were compared with treatment tubes in which floods of 15, 30, 60 and 90 days, and droughts of 60, 90 and 120 days were simulated in the field. Flooding and drought were found to reduce number of individuals in all soil faunal groups, but the response to drought was slower and not in proportion to the expected decrease of the water content. The results of the simulated floods in particular show the value of the STAFD method for the investigation of such extreme events in natural habitats.As micro, macro e mesofaunas no solo respondem frequentemente à variação das condições ambientais, o que resulta em alterações na abundância e na estrutura da comunidade. Os efeitos das alterações nos parâmetros do solo são normalmente determinados com amostras recolhidas no campo e trazidas ao laboratório, ou seja, onde as condições ambientais naturais podem não ser aplicáveis. Criamos um método (STAFD – tubos de amostra de solo para inundações e secas artificiais), que simula o estado hidrológico do solo in situ com núcleos implantados. As amostras de controle foram comparadas com amostras de tratamentos em que foram simuladas inundações de 15, 30, 60 e 90 dias e secas de 60, 90 e 120 dias no campo. Verificou-se que as inundações e a seca reduziram a quantidade de individuos em todos os grupos de fauna de solo, mas a resposta à seca foi mais lenta e não proporcional à redução prevista no teor de água. Os resultados das inundações simuladas demonstram, em especial, o valor do método STAFD para a investigação desse tipo de eventos extremos nos habitats naturais

    Respostas e adaptações de comunidades de colêmbolos (Hexapoda: Collembola) a condições de inundação e hipoxia

    Get PDF
    Standard ecological methods (pitfall traps, trunk eclectors and soil cores) were used to evaluate collembolan community responses to different flooding intensities. Three sites of a floodplain habitat near Mainz, Germany, with different flooding regimes were investigated. The structures of collembolan communities are markedly different depending on flooding intensity. Sites more affected by flooding are dominated by hygrophilic and hygrotolerant species, whereas the hardwood floodplain is dominated by mesophilic species. The survival strategies of the hygrophilic and hygrotolerant species include egg diapause and passive drifting. The physiological adaptations to hypoxic conditions of several collembolan species were analyzed using a microcalorimeter. The activities were tested under normoxic and hypoxic/anoxic conditions as well as during post-hypoxic recovery. Lactate was increased after hypoxic intervals in the species studied, suggesting that, in addition to a massive decrease in metabolic rate, a modest glycolytic activity may be involved in the tolerance to hypoxia.Foram utilizados os métodos ecológicos padrão (armadilhas "pitfall", armadilhas de tronco e amostras de solo) para avaliar as respostas de comunidade de colêmbolos a diferentes intensidades de inundação. Foram investigados três locais de um habitat de leitos de inundação perto de Mainz, Alemanha, com diferentes regimes de inundação. As estruturas das comunidades de colêmbolos foram nitidamente diferentes conforme a intensidade das inundações. Nos locais mais afetados por inundações, as espécies higrofílicas e higrotolerantes dominaram, ao passo que as espécies mesofílicas foram dominantes nos locais de leitos de inundação com angiospermas. As estratégias de sobrevivência das espécies higrofílicas e higrotolerantes incluem a diapausa dos ovos e o deslocamento passivo. Foi testada a adaptação fisiológica a condições hipóxicas de espécies selecionadas de colêmbolos através de análises por microcalorimetria. A atividade das espécies foi testada em condições normóxicas e hipóxicas/anóxicas e durante a recuperação pós-hipoxia. Verificou-se que o lactato aumentava após condições hipóxicas nas espécies avaliadas, o que sugere que, além de um decréscimo massivo na atividade metabólica, deve haver também certa atividade glicolítica associada à tolerância à hipoxia

    Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma

    Get PDF
    Primary aldosteronism is the most frequent cause of secondary hypertension and is associated with increased morbidity and mortality compared with hypertensive controls. The central diagnostic challenge is the differentiation between bilateral and unilateral disease, which determines treatment options. Bilateral adrenal venous sampling, currently recommended for differential diagnosis, is an invasive procedure with several drawbacks, making it desirable to develop novel noninvasive diagnostic tools. When investigating the expression pattern of chemokine receptors by quantitative real-time polymerase chain reaction and immunohistochemistry, we observed high expression of CXCR4 (CXC chemokine receptor type 4) in aldosterone-producing tissue in normal adrenals, adjacent adrenal cortex from adrenocortical adenomas, and in aldosterone-producing adenomas (APA), correlating strongly with the expression of CYP11B2 (aldosterone synthase). In contrast, CXCR4 was not detected in the majority of nonfunctioning adenomas that are frequently found coincidently. The specific CXCR4 ligand 68Ga-pentixafor has recently been established as radiotracer for molecular imaging of CXCR4 expression and showed strong and specific binding to cryosections of APAs in our study. We further investigated 9 patients with primary aldosteronism because of APA by 68Ga-pentixafor-positron emission tomography. The tracer uptake was significantly higher on the side of increased adrenocortical aldosterone secretion in patients with APAs compared with patients investigated by 68Ga-pentixafor-positron emission tomography for other causes. Molecular imaging of aldosterone-producing tissue by a CXCR4-specific ligand may, therefore, be a highly promising tool for noninvasive characterization of patients with APAs

    World ocean review: Mit den Meeren leben 5. Die Küsten - ein wertvoller Lebensraum unter Druck

    Get PDF
    Die fünfte Ausgabe des „World Ocean Review“ (WOR) beschäftigt sich mit dem Lebensraum Küste und den vielfältigen Erwartungen, die an diesen Lebensraum gestellt werden. Der WOR 5 gibt einen Einblik in die über Jahrmillionen zurückreichende Geschichte, erläutert die Theorie der Kontinentalveschiebung und erörtert wie sich das Gesicht der Küsten verändert hat. Er zeigt auf, wie die vielfältigen Ökosystemleistungen der Küsten immer mehr unter Druck geraten und stellt Maßnahmen vor, die in Zukunft notwendig sein werden, um den Bedrohungen durch Klimawandel und Naturkatastrophen Herr zu werden

    World Ocean Review 2015 : living with the oceans 5. Coasts - a vital habitat under pressure

    Get PDF
    The fifth World Ocean Review (WOR) explores the coastal habitat and the diverse expectations upon this habitat. It provides a glimpse into millions of years of history, elucidates the theory of continental drift and discusses the many ways in which coasts have changed. It also illustrates how the diverse ecosystem services rendered by the coasts are being subjected to increasing pressure, and profiles measures that will be necessary in the future to respond effectively to the threats from both climate change and natural disasters

    A Meta-analysis of Gene Expression Signatures of Blood Pressure and Hypertension

    Get PDF
    Genome-wide association studies (GWAS) have uncovered numerous genetic variants (SNPs) that are associated with blood pressure (BP). Genetic variants may lead to BP changes by acting on intermediate molecular phenotypes such as coded protein sequence or gene expression, which in turn affect BP variability. Therefore, characterizing genes whose expression is associated with BP may reveal cellular processes involved in BP regulation and uncover how transcripts mediate genetic and environmental effects on BP variability. A meta-analysis of results from six studies of global gene expression profiles of BP and hypertension in whole blood was performed in 7017 individuals who were not receiving antihypertensive drug treatment. We identified 34 genes that were differentially expressed in relation to BP (Bonferroni-corrected p<0.05). Among these genes, FOS and PTGS2 have been previously reported to be involved in BP-related processes; the others are novel. The top BP signature genes in aggregate explain 5%–9% of inter-individual variance in BP. Of note, rs3184504 in SH2B3, which was also reported in GWAS to be associated with BP, was found to be a trans regulator of the expression of 6 of the transcripts we found to be associated with BP (FOS, MYADM, PP1R15A, TAGAP, S100A10, and FGBP2). Gene set enrichment analysis suggested that the BP-related global gene expression changes include genes involved in inflammatory response and apoptosis pathways. Our study provides new insights into molecular mechanisms underlying BP regulation, and suggests novel transcriptomic markers for the treatment and prevention of hypertension

    Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

    Get PDF
    IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570
    corecore